Archivio Mensile: February 2011

Advocacy & Education: How one Person Took Her Story to the Professionals

Frequently in conversations with people suffering from one of the variouspemphigaldiseases, one is taken back by how common it is to hear that it took months to be diagnosedand even then, most doctors and dentists only

Pubblicato in Issue 62 - Fall 2010

MindulnessSeasons of Life & Chronic Illness

A painting by Flemish painter Dr. Hugo Heyrman has forever changed how I now think of the stages of life. The name of the painting which has touched me so deeply is “City Leaf”. There is a special beauty in

Pubblicato in Issue 62 - Fall 2010

Q&A: Questions from the forums, email, phone calls, and Facebook postings

Answers from the IPPF Peer Health Coaches Q: I’ve heard of some success with tacrolimus ointment for BPthoughts? A: Some doctors report success with tacrolimus ointment for BP, that it can help limit the use of more potent

Pubblicato in Issue 62 - Fall 2010

What doctors wish their patients knew

As the health-reform law takes effect over the next several years, some 32 million newly insured Americans will gain access to a regular doctor. They will soon learn what others already know: Getting the best care from your doctor requires

Pubblicato in Around the Globe

When Patients Share Their Stories, Health May Improve

A gifted artist in his early 60s, the patient was a liver transplant candidate who learned he had hepatitis B some 20 years earlier. Despite the worsening fatigue that accompanied his liver failure, he threw himself into preparing for his

Pubblicato in Around the Globe

Fight to defeat US pemphigoid pemphigus disease

Pemphigus, pemphigoid, strange names, unknown names called orphan diseases that affect the skin and mucous membranes. This is because one of their own, Oceane was reached, that young WJC (Youth City Council) decided to mobilize and motivate as many people.

Pubblicato in Around the Globe

New Chief Revises Goals and Spending for Pfizer

Pfizer, the drug maker, announced plans Tuesday to slash its research spending by as much as $2.9 billion in the next two years, including closing the English labs that invented Viagra.The company stock soared 5.5 percent on Tuesday, to $19.22,

Pubblicato in Around the Globe
JOIN TODAY!
The P/P Registry has been approved by the Western Institutional Review Board (WIRB) and is actively enrolling participants.

ENGLISH VERSION

SPANISH VERSION